BioSpace News Archive

Children’s Hospital of Philadelphia and MOREHealth, a global healthcare company, announced their new agreement that enables patients access to CHOP’s exceptional physicians through MOREHealth’s Physician Collaboration Platform™.

Animal Data has Potential Implications for Ongoing COVID-19 Prevention Study Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies

GSK today launched a national campaign to help increase low rates of vaccination among older adults. The campaign, Brought to You By Vaccines , will educate adults ages 50 and older about the value of vaccines and the urgent need to talk to their healthcare provider or pharmacist about the recommended vaccines they need or may have re

BehaVR , a leading innovator of virtual reality digital wellness and digital therapeutics experiences, today announced that it has begun a new partnership aimed at leveraging virtual reality experienc

Children’s National Hospital’s Pediatric study results mirror disparities found in adult populations across the U.S

July 2020 Services ISM® Report On Business®; Business Activity Index at 67.2%; New Orders Index at 67.7%; Employment Index at 42.1%; Supplier Deliveries Index at 55.2%

Guide provides information on how to manage students or staff with COVID-19 symptoms or who have been exposed to the virus

- University of California Irvine is the first California site participating in Celularity’s CYNK-001-COVID-19 clinical trial NCT04365101 using Celularity’s investigational immunotherapy to treat adults who tested COVID-19 positive in underserved and disproportionately affected populations. - CYNK-001 is the only cryopreserved allogeneic, off-the-shelf NK cell therapy developed from placental hematopoietic stem cells. [05-Augu

B. Braun Medical Inc. and Kerma Medical Products, Inc. announced a collaboration to improve the development and delivery of healthcare products and services, with an emphasis on veteran, minority and other underserved communities.

The Food and Drug Administration (FDA) has cleared the SOMATOM On.site, a mobile head computed tomography (CT) scanner from Siemens Healthineers that enables a critically ill patient to receive CT head imaging in the intensive care unit (ICU) while remaining in bed. Performing a CT head examination at